Jul 8, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Boehringer Ingelheim And Orexo Report Progress In Their Pain And Inflammatory Disease
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2452184" data-attributes="member: 124445"><p>Orexo AB (STO: ORX) and Boehringer Ingelheim announced that Boehringer Ingelheim has selected a development candidate resulting from the worldwide exclusive research, development and commercialisation agreement which Boehringer Ingelheim had signed in November 2005 with Biolipox, a Swedish research-based pharmaceutical company acquired by Orexo in October 2007. The aim of the collaboration is to develop a new class of medication with a novel mechanism of action for the treatment of pain and inflammatory diseases...<a href="http://feedads.g.doubleclick.net/~a/wpDGEnxbWqvpaydqv0DyxUhThmE/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/wpDGEnxbWqvpaydqv0DyxUhThmE/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/wpDGEnxbWqvpaydqv0DyxUhThmE/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/wpDGEnxbWqvpaydqv0DyxUhThmE/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/zK-tsItmwsw" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/zK-tsItmwsw/3Pd4" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2452184, member: 124445"] Orexo AB (STO: ORX) and Boehringer Ingelheim announced that Boehringer Ingelheim has selected a development candidate resulting from the worldwide exclusive research, development and commercialisation agreement which Boehringer Ingelheim had signed in November 2005 with Biolipox, a Swedish research-based pharmaceutical company acquired by Orexo in October 2007. The aim of the collaboration is to develop a new class of medication with a novel mechanism of action for the treatment of pain and inflammatory diseases...[URL="http://feedads.g.doubleclick.net/~a/wpDGEnxbWqvpaydqv0DyxUhThmE/0/da"][IMG]http://feedads.g.doubleclick.net/~a/wpDGEnxbWqvpaydqv0DyxUhThmE/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/wpDGEnxbWqvpaydqv0DyxUhThmE/1/da"][IMG]http://feedads.g.doubleclick.net/~a/wpDGEnxbWqvpaydqv0DyxUhThmE/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/zK-tsItmwsw[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/zK-tsItmwsw/3Pd4]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top